- Previous Close
173.20 - Open
172.00 - Bid 175.80 x --
- Ask 170.80 x --
- Day's Range
170.00 - 176.40 - 52 Week Range
80.00 - 193.80 - Volume
186,062 - Avg. Volume
158,303 - Market Cap (intraday)
13.68B - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
26.76 - EPS (TTM)
6.39 - Earnings Date Nov 4, 2024 - Nov 8, 2024
- Forward Dividend & Yield 2.50 (1.44%)
- Ex-Dividend Date Jun 25, 2024
- 1y Target Est
163.00
Astra Industrial Group Company, through its subsidiaries, engages in the pharmaceuticals, specialty chemicals, power, steel, and mining businesses worldwide. The company develops, manufactures, markets, and distributes branded generic and under-licensed pharmaceuticals products in various therapeutic areas, including CNS, cardiovascular, anti-infective, respiratory, and muscular skeletal system; and produces masterbatches, dust-free additives, and custom-made thermoplastic compounds, and liquid and paste colorants for polymer manufacturing and polymer converting, and plastic processing industries. It also manufactures, imports, and distributes a range of agrochemicals, fertilizers, public health and veterinary pesticides, seeds, and other agricultural inputs; and produces pre-engineered steel buildings and steel structures, as well as steel billets and rebars. In addition, the company explores for ores and minerals. Further, it builds, operates, manages, and invests in industrial plants. Additionally, it is involved in the metal based construction of buildings and building frames. The company was incorporated in 1988 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.
www.aig.saRecent News: 1212.SR
View MorePerformance Overview: 1212.SR
Trailing total returns as of 8/29/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1212.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1212.SR
View MoreValuation Measures
Market Cap
13.86B
Enterprise Value
13.34B
Trailing P/E
27.10
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.45
Price/Book (mrq)
6.17
Enterprise Value/Revenue
4.29
Enterprise Value/EBITDA
18.23
Financial Highlights
Profitability and Income Statement
Profit Margin
17.88%
Return on Assets (ttm)
8.95%
Return on Equity (ttm)
24.37%
Revenue (ttm)
3.11B
Net Income Avi to Common (ttm)
500.88M
Diluted EPS (ttm)
6.39
Balance Sheet and Cash Flow
Total Cash (mrq)
1.57B
Total Debt/Equity (mrq)
46.88%
Levered Free Cash Flow (ttm)
181.14M